JO
CSCI

John Overdeck’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

John Overdeck’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-16
Closed -$14K – 3044
2015
Q3 		$14K Buy
+16
New +$23.3K ﹤0.01% 2117
2015
Q1 		– Sell
-10
Closed -$61K – 2900
2014
Q4 		$61K Buy
+10
New +$84K ﹤0.01% 2155
2014
Q1 		– Sell
-1
Closed -$16K – 2306
2013
Q4 		$16K Buy
+1
New +$13.3K ﹤0.01% 2143

Other funds holding CSCI

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

John Overdeck's CSCI Position: Q4 2015 in Review

John Overdeck sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2015, closing a stake of 16 shares — an estimated $14K sold.

John Overdeck first reported a position in CSCI in Q4 2013 and held it in 3 quarters. The position peaked at $61K in Q4 2014. 17 funds tracked by Wall St. Rank hold CSCI as of Q4 2015.

  • John Overdeck reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • John Overdeck sold 16 COSCIENS Biopharma Inc. Common Stock shares in Q4 2015, an estimated $14K.
  • John Overdeck first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2013 and held it in 3 quarters.
  • John Overdeck's COSCIENS Biopharma Inc. Common Stock position peaked at $61K in Q4 2014.
  • 17 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2015.

Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.